4.7 Article

Age, vascular health, and Alzheimer disease biomarkers in an elderly sample

期刊

ANNALS OF NEUROLOGY
卷 82, 期 5, 页码 706-718

出版社

WILEY
DOI: 10.1002/ana.25071

关键词

-

资金

  1. NIH NINDS
  2. NIA [R01 NS097495, R01 AG56366, U01 AG06786, P50 AG16574/P1, P50 AG16574, R01 AG11378, R01 AG41851]
  3. GHR Foundation
  4. Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation
  5. Liston Award
  6. Elsie and Marvin Dekelboum Family Foundation
  7. Schuler Foundation
  8. Opus Building NIH grant [C06 RR018898]
  9. Rochester Epidemiology Project [R01 AG034676]

向作者/读者索取更多资源

ObjectiveTo investigate the associations between age, vascular health, and Alzheimer disease (AD) imaging biomarkers in an elderly sample. MethodsWe identified 430 individuals along the cognitive continuum aged >60 years with amyloid positron emission tomography (PET), tau PET, and magnetic resonance imaging (MRI) scans from the population-based Mayo Clinic Study of Aging. A subset of 329 individuals had fluorodeoxyglucose (FDG) PET. We ascertained presently existing cardiovascular and metabolic conditions (CMC) from health care records and used the summation of presence/absence of hypertension, hyperlipidemia, cardiac arrhythmias, coronary artery disease, congestive heart failure, diabetes mellitus, and stroke as a surrogate for vascular health. We used global amyloid from Pittsburgh compound B PET, entorhinal cortex tau uptake (ERC-tau) from tau-PET, and neurodegeneration in AD signature regions from MRI and FDG-PET as surrogates for AD pathophysiology. We dichotomized participants into CMC = 0 (CMC-) versus CMC > 0 (CMC+) and tested for age-adjusted group differences in AD biomarkers. Using structural equation models (SEMs), we assessed the impact of vascular health on AD biomarker cascade (amyloid leads to tau leads to neurodegeneration) after considering the direct and indirect age, sex, and apolipoprotein E effects. ResultsCMC(+) participants had significantly greater neurodegeneration than CMC- participants but did not differ by amyloid or ERC-tau. The SEMs showed that (1) vascular health had a significant direct and indirect impact on neurodegeneration but not on amyloid; and (2) vascular health, specifically the presence of hyperlipidemia, had a significant direct impact on ERC-tau. InterpretationVascular health had quantifiably greater impact on neurodegeneration in AD regions than on amyloid deposition. Longitudinal studies are warranted to clarify the relationship between tau deposition and vascular health. Ann Neurol 2017;82:706-718

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据